Direct evidence on the efficacy of GnRH agonist in recurrent steroid cell tumor-not otherwise specified

ConclusionSome ovarian SCT-NOS have GnRH receptors; thus, GnRHa may have a reducing effect for these tumors without major adverse event.

Source: Gynecologic Oncology Reports - July 17, 2019 Category: OBGYN Source Type: research